학술논문

Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Covid-19: Primary Results of the PREVENT-HD Randomized Clinical Trial
Document Type
Journal
Source
CIRCULATION; DEC 20 2022, 146 25, pE580-pE580, 1p.
Subject
Language
English
ISSN
15244539